Zhuoying Feng

Dr. Zhuoying Feng

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2021 in Genes & Diseases
Verified
Journal Article
Open access
ZFZhuoying Feng
Zhuoying Feng
FZFanghang Zhou
Fanghang Zhou
MTMiaomiao Tan
Miaomiao Tan
TWTingting Wang
Tingting Wang
YCYing Chen
Ying Chen
Ming-Liang HeMing-Liang He
Ming-Liang He
The latent infection by herpes virus type 1 (HSV-1) may be lifelong in trigeminal ganglia and a suspected cause of Alzheimer's Disease (AD) and Amyotrophic lateral sclerosis (ALS). Whether and how N6-methyladenosine (m6A) modification of viral RNAs affects virus infection are poorly understood. Here, we report that HSV-1 infection enhanced the expression of m6A writers (METTL3, METTL14) and readers (YTHDF1/2/3) at the early infection stage and decreased their expression later on, while suppressed the erasers' (FTO, ALBKH5) expression immediately upon infection to facilitate viral replication. Inhibiting m6A modification by 3-deazaadenosine (DAA) significantly decreased viral replication and reduced viral reproduction over 1000 folds. More interestingly, depleting the writers and readers by siRNAs inhibited virus replication and reproduction; whereas depleting the erasers promoted viral replication and reproduction. Silencing YTHDF3 strikingly decreased viral replication by up to 90%, leading to reduction of up to 10-fold viral replication and over 100-fold virus reproduction, respectively. Depletion of m6A initiator METTL3 (by 60%–70%) by siRNA correlatedly decreased viral replication 60%–70%, and reduced virus yield over 30-fold. Consistently, ectopic expression of METTL3 largely increased virus yield. METTL3 knockdown suppressed the HSV-1 intermediate early and early genes (ICP0, ICP8 and UL23) and late genes (VP16, UL44, UL49 and ICP47); while ectopic expression of METTL3 upregulated these gene expression. Results from our study shed the lights on the importance for m6A modification to initiate HSV-1 early replication. The components of m6A modification machinery, particularly m6A initiator METTL3 and reader YTHDF3, would be potential important targets for combating HSV-1 infections.

21 January 2026 in Hepatology Communications
Verified
Journal Article
Open access
XWXinjia Wang
Xinjia Wang
LBLu Bian
Lu Bian
ZFZhuoying Feng
Zhuoying Feng
KOKyle O’sHaughnessy
Kyle O’sHaughnessy
AKAndrew C. Kwong
Andrew C. Kwong
XWXianfang Wu
Xianfang Wu
Background: The 148M variant of PNPLA3 is a major genetic risk factor for metabolic dysfunction–associated steatotic liver disease (MASLD), yet its macrophage-specific role remains unclear. We investigated how PNPLA3-148M alters macrophage behavior and multicellular liver pathology under lipotoxic stress. Methods: We used a human induced pluripotent stem cell (iPSC)-derived multicellular liver culture comprising hepatocytes, hepatic stellate cells (HSCs), and isogenic macrophages that differed only at PNPLA3 (148M vs. 148I). Cultures were exposed to lipotoxic conditions to induce MASLD. We quantified inflammatory cytokines, oxidative stress, hepatocyte lipid accumulation, and HSC activation. Macrophage death pathways were profiled (apoptosis, pyroptosis, necroptosis), with emphasis on RIPK3 expression and phosphorylation. Downstream effects on hepatocytes and HSCs were assessed. Results: Under lipotoxic stress, 148M macrophages amplified MASLD-like features. PNPLA3 transcripts were induced in macrophages—rising in iPSC-derived macrophages from lipotoxic cultures, and in Kupffer cells isolated from murine MASLD. Single-cell RNA-seq further confirmed PNPLA3 expression in human liver macrophage clusters, in addition to hepatocytes and HSCs. Although PNPLA3 mRNA was comparable between genotypes, 148M macrophages displayed higher PNPLA3 protein and increased necroptosis, evidenced by elevated RIPK3 expression and phosphorylation without changes in apoptosis or pyroptosis. Integrative analyses identified NACC1 as a key transcriptional regulator of RIPK3 , with NF-κB–linked upregulation of NACC1 in 148M macrophages. NACC1 inhibition (genetic or NIC3) reduced RIPK3, suppressed necroptosis, and lowered pro-inflammatory cytokine secretion. NIC3 additionally decreased hepatocyte lipid accumulation and ATP and diminished HSC activation markers. Conclusions: The PNPLA3 148M variant promotes MASLD through a macrophage-specific NF-κB–NACC1–RIPK3 axis that enhances necroptosis and inflammatory signaling, thereby exacerbating hepatocyte steatosis and HSC activation. NACC1 emerges as a tractable therapeutic target for genetically at-risk individuals.

24 April 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
KDKaitlyn Daff
Kaitlyn Daff
YHYingchun Han
Yingchun Han
ZFZhuoying Feng
Zhuoying Feng
MUMala Upadhyay
Mala Upadhyay
VSVyshnavi Sivampeta
Vyshnavi Sivampeta
GCGail A.M. Cresci
Gail A.M. Cresci
Ethanol exposure causes microbial imbalance, damages the gut barrier, and increases oxidative stress along the gut–liver axis, leading to the development and progression of alcohol-associated liver disease (ALD). Arginine is a conditionally essential amino acid that may play a key role in maintaining redox homeostasis and mediating host–microbiota crosstalk. We hypothesized that supplemental arginine provided during chronic ethanol exposure in mice would mitigate oxidative damage via the gut–liver axis. Our findings suggest that arginine supplementation mediated hepatic steatosis, preserved body weight and fat, and reduced oxidative stress in the gut–liver axis. These changes were associated with alterations in gut microbiota composition and function. These data support a potential role for arginine supplementation in mitigating ethanol-induced oxidative damage via the gut–liver axis.